No Data
No Data
Analysts Offer Insights on Healthcare Companies: Aprea Therapeutics (APRE), Biogen (BIIB) and Mesoblast Limited (OtherMEOBF)
Indivi to Collaborate With Biogen to Advance Digital Health Technology and Digital Biomarkers for Parkinson's Disease
BASEL, Switzerland--(BUSINESS WIRE)--Indivi, a leading MedTech company headquartered in Basel, Switzerland, has entered into an agreement with Biogen to advance digital health technology and develop d
Biogen Inc. (BIIB) Dips More Than Broader Market: What You Should Know
Forecasting The Future: 18 Analyst Projections For Biogen
During the last three months, 18 analysts shared their evaluations of Biogen (NASDAQ:BIIB), revealing diverse outlooks from bullish to bearish.The table below provides a snapshot of their recent ratin
Express News | Truist Securities Reiterates Buy on Biogen, Maintains $340 Price Target
Biogen Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 03/25/2024 55.93% Truist Securities → $340 Reiterates Buy → Buy 03/05/2024 66.93% RBC Capital → $364 Reite
No Data